Publication Details

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
Newer antibodies against CD20

Newer antibodies against CD20 (April 2020)

Newer antibodies against CD20 are beginning to offer alternatives to rituximab for some people with lymphoma. This factsheet covers: antibodies targeting CD20; ofatumumab (Arzerra®); obinutuzumab (Gazyvaro®). It considers who can have these antibodies, how they are given, possible side effects.

Author(s)
Lymphoma Action
Place of publication
Aylesbury
Publisher
Date of publication
April 2020
Pages
10pp
Format
Factsheet
Language
English
Flesch readability score
48.0
Download this resource
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm